Detalhe da pesquisa
1.
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer.
Am J Gastroenterol
; 119(4): 739-747, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787643
2.
Management of Functional Pancreatic Neuroendocrine Neoplasms.
Curr Treat Options Oncol
; 24(7): 725-741, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103745
3.
CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors.
Radiol Med
; 127(7): 691-701, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717429
4.
Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management.
Front Med (Lausanne)
; 11: 1327864, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357651
5.
Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection.
J Clin Med
; 13(9)2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38731064
6.
When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors?
J Clin Med
; 12(14)2023 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37510695
7.
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors.
Expert Rev Gastroenterol Hepatol
; 17(8): 785-793, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497604
8.
Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia.
Endocrine
; 82(2): 435-441, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338723
9.
The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.
J Clin Med
; 11(20)2022 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36294448
10.
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors.
Endocrine
; 76(2): 484-490, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149933